Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
January 29, 2026
Bispecific Antibody Therapy for Multiple Myeloma: A Practical Toolkit
Cesar Rodriguez, Cyrille Touzeau, Edvan de Queiroz Crusoe, et al.
Blood Cancer Journal
|
December 6, 2025
Survival impact of anti-CD38-based quadruplet regimens in transplant-ineligible newly diagnosed multiple myeloma: a network meta-analysis and reconstructed individual patient data meta-analysis
João Tadeu Damian Souto Filho, Lucas Oliveira Cantadori, Edvan de Queiroz Crusoe, et al.
Revista Brasileira De Hematologia E Hemoterapia
|
May 22, 2016
Bilateral breast plasmacytoma: a clinical case report
Thais Rodrigues da Cunha Fischer, Fabiana Higashi, Edvan de Queiroz Crusoe, et al.
Blood Cancer Journal
|
March 14, 2025
Daratumumab-based quadruplet versus triplet induction regimens in transplant-eligible newly diagnosed multiple myeloma: a systematic review and meta-analysis
João Tadeu Damian Souto Filho, Lucas Oliveira Cantadori, Edvan de Queiroz Crusoe, et al.
Revista Brasileira De Hematologia E Hemoterapia
|
August 2, 2013
Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2012
Vânia Tietsche de Moraes Hungria, Edvan de Queiroz Crusoe, Adriana Alvarez Quero, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 3, 2014
Multiple myeloma: a rare case in an 8-year-old child
Edvan de Queiroz Crusoe, Ana Maria Marinho da Silva, Jozina Agareno, et al.
Revista Brasileira De Hematologia E Hemoterapia
|
November 19, 2017
For survival, the emergence of oligoclonal bands after multiple myeloma treatment is less important than achieving complete remission
Luiza Soares Vieira da Silva, Edvan de Queiroz Crusoe, Lais Rocha Guimarães de Souza, et al.
Hematology, Transfusion and Cell Therapy
|
September 16, 2022
Impact of the lactate dehydrogenase in association with the International Staging System prognostic score in multiple myeloma patients treated in real life
Maricy Almeida Viol Ferreira Lopes, Fabiana Higashi, Edvan de Queiroz Crusoe, et al.
Hematology, Transfusion and Cell Therapy
|
November 19, 2021
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. IV: CAR-T cell therapy for multiple myeloma patients
Angelo Maiolino, Luciano J Costa, Marcelo Pasquini, et al.
Revista Brasileira De Hematologia E Hemoterapia
|
November 20, 2016
Is it feasible to use granulocyte-colony stimulating factor alone to mobilize progenitor cells in multiple myeloma patients induced with a cyclophosphamide, thalidomide and dexamethasone regimen?
Edvan de Queiroz Crusoe, Fabiana Higashi, Gracia Aparecida Martinez, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Clinical Lymphoma, Myeloma & Leukemia
|
January 29, 2026
Bispecific Antibody Therapy for Multiple Myeloma: A Practical Toolkit
Cesar Rodriguez, Cyrille Touzeau, Edvan de Queiroz Crusoe, et al.
Blood Cancer Journal
|
December 6, 2025
Survival impact of anti-CD38-based quadruplet regimens in transplant-ineligible newly diagnosed multiple myeloma: a network meta-analysis and reconstructed individual patient data meta-analysis
João Tadeu Damian Souto Filho, Lucas Oliveira Cantadori, Edvan de Queiroz Crusoe, et al.
Revista Brasileira De Hematologia E Hemoterapia
|
May 22, 2016
Bilateral breast plasmacytoma: a clinical case report
Thais Rodrigues da Cunha Fischer, Fabiana Higashi, Edvan de Queiroz Crusoe, et al.
Blood Cancer Journal
|
March 14, 2025
Daratumumab-based quadruplet versus triplet induction regimens in transplant-eligible newly diagnosed multiple myeloma: a systematic review and meta-analysis
João Tadeu Damian Souto Filho, Lucas Oliveira Cantadori, Edvan de Queiroz Crusoe, et al.
Revista Brasileira De Hematologia E Hemoterapia
|
August 2, 2013
Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2012
Vânia Tietsche de Moraes Hungria, Edvan de Queiroz Crusoe, Adriana Alvarez Quero, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 3, 2014
Multiple myeloma: a rare case in an 8-year-old child
Edvan de Queiroz Crusoe, Ana Maria Marinho da Silva, Jozina Agareno, et al.
Revista Brasileira De Hematologia E Hemoterapia
|
November 19, 2017
For survival, the emergence of oligoclonal bands after multiple myeloma treatment is less important than achieving complete remission
Luiza Soares Vieira da Silva, Edvan de Queiroz Crusoe, Lais Rocha Guimarães de Souza, et al.
Hematology, Transfusion and Cell Therapy
|
September 16, 2022
Impact of the lactate dehydrogenase in association with the International Staging System prognostic score in multiple myeloma patients treated in real life
Maricy Almeida Viol Ferreira Lopes, Fabiana Higashi, Edvan de Queiroz Crusoe, et al.
Hematology, Transfusion and Cell Therapy
|
November 19, 2021
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. IV: CAR-T cell therapy for multiple myeloma patients
Angelo Maiolino, Luciano J Costa, Marcelo Pasquini, et al.
Revista Brasileira De Hematologia E Hemoterapia
|
November 20, 2016
Is it feasible to use granulocyte-colony stimulating factor alone to mobilize progenitor cells in multiple myeloma patients induced with a cyclophosphamide, thalidomide and dexamethasone regimen?
Edvan de Queiroz Crusoe, Fabiana Higashi, Gracia Aparecida Martinez, et al.
Page
of 2